These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14069668)

  • 1. AMYLO-1,6-GLUCOSIDASE ACTIVITY IN LEUCOCYTES FROM PATIENTS WITH GLYCOGEN STORAGE DISEASE.
    STEINITZ K; BODUR H; ARMAN T
    Clin Chim Acta; 1963 Sep; 8():807-9. PubMed ID: 14069668
    [No Abstract]   [Full Text] [Related]  

  • 2. AMYLO-1,6-GLUCOSIDASE ACTIVITY IN NORMAL LEUCOCYTES AND IN LEUCOCYTES OF PATIENTS WITH GLYCOGEN-STORAGE DISEASE.
    HUIJING F
    Clin Chim Acta; 1964 Mar; 9():269-72. PubMed ID: 14152344
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible prenatal diagnosis of type III glycogenosis.
    Maire I; Mathieu M
    J Inherit Metab Dis; 1986; 9(1):89-91. PubMed ID: 2941619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution to the case reports of dysglucogenosis. A case of "limit dextrinosis" (lack of amylo-1,6-glucosidase). Functional and enzymatic diagnosis].
    PENA J
    Rev Esp Pediatr; 1961; 17():437-45. PubMed ID: 14485050
    [No Abstract]   [Full Text] [Related]  

  • 5. Amylo-1,6-glucosidase activity in cultured cells: a deficiency in type III glycogenosis with prenatal studies.
    Besley GT; Cohen PT; Faed MJ; Wolstenholme J
    Prenat Diagn; 1983 Jan; 3(1):13-9. PubMed ID: 6221240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amylo-1,60glucosidase deficiency (glycogenosis type III) in the Faroe Islands.
    Cohn J; Wang P; Hauge M; Henningsen K; Jensen B; Svejgaard A
    Hum Hered; 1975; 25(2):115-26. PubMed ID: 1056894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte debranching enzyme in glycogen storage disease.
    WILLIAMS HE; KENDIG EM; FIELD JB
    J Clin Invest; 1963 May; 42(5):656-60. PubMed ID: 14000867
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of a fluorimetric for determining the activity of amylo-1,6-glucosidase in leukocytes for confirming the diagnosis of glycogen storage disease type III].
    Miadi-Messaoud H; Mili A; Ben Khalifa H; Limem K
    Ann Biol Clin (Paris); 2011; 69(1):41-5. PubMed ID: 21463994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amylo-1,6-glucosidase in human fibroblasts: studies 3 glycogen storage disease.
    Justice P; Ryan C; Hsia DY; Krmpotik E
    Biochem Biophys Res Commun; 1970 May; 39(3):301-6. PubMed ID: 5270292
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the casuistics of dysglucogenosis. A case of "dextrinosis limit" (absence of amylo-1, 6-glucosidase)].
    PENA J
    Rev Clin Esp; 1961 Nov; 83():292-5. PubMed ID: 14485051
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies in glycogen storage disease type 3: kinetics of amylo-1,6-glucosidase in human erythrocytes.
    Garatun-Tjeldstö E; Garatun-Tjeldstö O
    Scand J Clin Lab Invest; 1971 May; 27(3):269-72. PubMed ID: 5281102
    [No Abstract]   [Full Text] [Related]  

  • 12. A simple assay for amylo-1,6-glucosidase to detect heterozygotes for glycogenosis type III in erythrocytes.
    Shin YS; Ungar R; Rieth M; Endres W
    Clin Chem; 1984 Oct; 30(10):1717-8. PubMed ID: 6236913
    [No Abstract]   [Full Text] [Related]  

  • 13. A rapid micro assay method for amylo-1,6-glucosidase.
    Nelson TE; Larner J
    Anal Biochem; 1970 Jan; 33(1):87-101. PubMed ID: 5263224
    [No Abstract]   [Full Text] [Related]  

  • 14. [Debranching enzyme activity in leukocytes and glycogen content of erythrocytes in patients with type III glycogenosis].
    Pieniazek D; Pronicka E; Miłoszewska E; Maciejko D; Gruszczyńska B
    Pediatr Pol; 1983 May; 58(5):447-53. PubMed ID: 6226925
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined action of oligo-1, 4--1,4-glucantransferase and amylo-1,6-glucosidase in debranching glycogen.
    BROWN DH; ILLINGWORTH B; CORI CF
    Nature; 1963 Mar; 197():980-2. PubMed ID: 14015932
    [No Abstract]   [Full Text] [Related]  

  • 16. [GLYCOGENIC POLYCORIA CAUSED BY ABSENCE OF AMYLO-1, 6-GLUCOSIDASE. HEPATOMUSCULAR FORM AND ISOLATED HEPATIC FORM].
    CHAPTAL J; JEAN R; DEPAULET C; GUILLAUMOT R; MOREL G
    Minerva Pediatr; 1964 Apr; 16():540-6. PubMed ID: 14166324
    [No Abstract]   [Full Text] [Related]  

  • 17. GLYCOGEN STORAGE DISEASE. BIOCHEMICAL AND CLINICAL DATA IN SIXTEEN CASES.
    VAN CREVELD ; HUIJING F
    Am J Med; 1965 Apr; 38():554-61. PubMed ID: 14271742
    [No Abstract]   [Full Text] [Related]  

  • 18. DIAGNOSIS OF GENERALIZED GLYCOGEN STORAGE DISEASE (POMPE'S DISEASE).
    HUIJING F; VAN CREVELD ; LOSEKOOT G
    J Pediatr; 1963 Nov; 63():984-7. PubMed ID: 14071054
    [No Abstract]   [Full Text] [Related]  

  • 19. A micro-radiochemical assay for alpha-1,4-glucosidase and its use in the assessment of type II glycogenosis (Pompe's disease).
    Nelson PV; Carey WF; Pollard AC
    Clin Chim Acta; 1977 Jun; 77(3):337-42. PubMed ID: 17494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glycogenosis caused by amylo-1,6-glucosidase deficiency. Myopathy as a lead finding in adults].
    Bröker HJ; Kuhn E; Fiehn W; Assmus H; Schröder JM
    Schweiz Med Wochenschr; 1981 Jun; 111(23):854-8. PubMed ID: 6791275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.